Skip to content

RYTM

Rhythm Pharmaceuticals, Inc.

Stock

$92.83−0.58 (−0.62%)Close Oct 2, 2026

Operating cash flow, 2025
−$116M

Operating cash flow

Operating cash flow by fiscal year

PeriodOperating cash flowYoY
2025−$116M—
2024−$114M—
2023−$136M—
2022−$173M—
2021−$146M—
2020−$122M—
2019−$123M—
2018−$62M—
2017−$29M—
2016−$23M—
2015−$7.0M—